An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Study found that the most robust results for the prioritisation of patients awaiting coronary revascularisation relate to a strategy employing risk stratification using conventional clinical information together with a single biomarker (estimated glomerular filtration rate)
1 Department of Epidemiology and Public Health, University College London, , UK
2 Centre for Medical Technology Assessment, Linköping University, , Sweden
3 Centre for Health Economics, University of York, , UK
4 Department of Health Sciences, University of Leicester, , UK
5 Department of Cardiology, Linköping University, , Sweden
6 Department of Primary Health Care, University of Bristol, , UK
7 Department of Health, London, UK
8 Cardiovascular Biology Research Centre, St George’s, University of London, , UK
9 Barts and the London NHS Trust, London, UK
* Corresponding author Email:
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document